Keyword: AstraZeneca

News

AstraZeneca to Buy Amolyt Pharma for up to $1.05 Billion

15.03.2024 -

Britain's AstraZeneca is to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases, more than $1...

News

AstraZeneca Plans £650 Million Investment in UK

07.03.2024 -

AstraZeneca, whose CEO Pascal Soriot has been critical of the UK business environment for the life sciences industry in the past, wants to invest a large sum at its...

News

AstraZeneca Completes Acquisitions of Gracell and Icosavax

23.02.2024 -

Within a few days, Anglo-Swedish drugmaker AstraZeneca has completed the acquisitions of Gracell Biotechnologies and Icosavax. Both transactions were announced in...

News

AstraZeneca to Construct New US Cell Therapy Facility

08.02.2024 -

In a move to launch its cell therapy platforms for critical cancer trials in the US, AstraZeneca is investing $300 million in a new facility in Rockville, Maryland. The...

News

AstraZeneca to Buy Cell Therapy Developer Gracell for Up to $1.2 Billion

03.01.2024 -

AstraZeneca has agreed to acquire Gracell Biotechnologies, a Chinese developer of cell therapies for the treatment of cancer and autoimmune diseases, for up to $1.2...

News

AstraZeneca to Buy Vaccine Company Icosavax for $1.1 Billion

14.12.2023 -

AstraZeneca has entered into an agreement to acquire Icosavax, a US biopharmaceutical company based in Seattle in a deal worth up to $1.1 billion. The company focuses on...

News

AstraZeneca Invests $245 Million in French Biotech Cellectis

02.11.2023 -

Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the...

News

AstraZeneca Granted Global Starmap AI License for Nanoform

24.10.2023 -

Nanoform, a nanoparticle medical technology company, has awarded AstraZeneca a global online STARMAP license. STARMAP is an AI-based digital rendition of CESS technology...